Core One Labs, Inc. is a biotechnology company, which engages in the manufacture of cannabis-infused strips. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2011-08-17. The firm is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. The company is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. The company also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.
Follow-Up Questions
Qui est le CEO de Core One Labs Inc ?
Mr. Joel Shacker est le Chief Executive Officer de Core One Labs Inc, il a rejoint l'entreprise depuis 2020.
Quelle est la performance du prix de l'action CLABF ?
Le prix actuel de CLABF est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Core One Labs Inc ?
Core One Labs Inc appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quel est la capitalisation boursière de Core One Labs Inc ?
La capitalisation boursière actuelle de Core One Labs Inc est de $NaN
